Search

Your search keyword '"Munn SR"' showing total 68 results

Search Constraints

Start Over You searched for: Author "Munn SR" Remove constraint Author: "Munn SR" Language english Remove constraint Language: english
68 results on '"Munn SR"'

Search Results

2. veteran advisor. Parting the Red Sea.

3. Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years.

5. Liver transplantation in Australia and New Zealand.

7. The New Zealand Liver Transplant Unit: Auckland District Health Board.

8. Selection pressure on the hepatitis B virus pre-S/S and P open reading frames in Tongan subjects with a chronic hepatitis B virus infection.

9. Evidence for reduced selection pressure on the hepatitis B virus core gene in hepatitis B e antigen-negative chronic hepatitis B.

10. Biliary complications following orthotopic liver transplantation: a 10-year audit.

11. Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealand-resident Tongans.

12. Low-cost, simultaneous, single-sequence genotyping of the HLA-A, HLA-B and HLA-C loci.

13. Genetic diversity and linkage disequilibrium in the Polynesian population of Niue Island.

14. Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy.

15. Analysis of intragraft gene and protein expression of the costimulatory molecules, CD80, CD86 and CD154, in orthotopic liver transplant recipients.

16. Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.

17. Prolongation of fully allogeneic skin graft survival in the rat by combined administration of costimulatory blockade and sirolimus.

18. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.

19. Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery.

21. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients.

22. NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice.

23. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.

24. Islet cell autoimmunity in NOD mice transgenic for HLA-DQ8 and lacking I-Ag7.

25. Diabetes mellitus and difficult laryngoscopy in renal and pancreatic transplant patients.

26. Islet cell autoimmunity in NOD mice transgenic to HLA-DQ8 and lacking I-Ag7.

27. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice.

28. Predictors of progression of diabetic nephropathy: implication for timing of kidney transplantation.

29. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.

30. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.

31. Effects of somatostatin on pulsatile insulin secretion: elective inhibition of insulin burst mass.

33. Prophylaxis for cytomegalovirus in pancreas transplant recipients using intravenous ganciclovir.

34. Fine specificity of class I MHC recognition in islet allografts.

35. Posttransplant hyperamylasemia is associated with decreased patient and graft survival in pancreas allograft recipients.

36. Current limitations to use of major histocompatibility complex transgenic donors for islet transplantation.

37. Masking donor major histocompatibility complex class I antigens on allogeneic islets.

38. Abrogation of islet immunogenicity using an anti-MHC class I monoclonal antibody.

39. NZMA code of ethics.

40. Ethics and abortion.

41. The effect of somatostatin 201-995 on the early course of porcine pancreaticoduodenal allotransplantation.

42. Purified canine islet autografts. Functional outcome as influenced by islet number and implantation site.

43. Histologic diagnosis of rejection by using cystoscopically directed needle biopsy specimens from dysfunctional pancreatoduodenal allografts with exocrine drainage into the bladder.

46. Morbidity during the first year after pancreas transplantation.

47. A prospective comparison of two preservation solutions in human pancreaticoduodenal transplantation.

48. Combined liver/pancreaticoduodenal procurement effect on allograft function.

50. Pancreas transplantation at Mayo: III. Multidisciplinary management.

Catalog

Books, media, physical & digital resources